Published

Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Expert opinion on drug discovery
Date: 2025-02-03
Source: PubMed
DOI: 10.1080/17460441.2025.2460674
PubMed: 39885729

Authors

de Miranda AS C B Toscano E Venna VR Graeff FG Teixeira AL

Watch author

Derived topics and classifications

psilocybin Depression Addiction Mechanism of Action Clinical Trial Treatment-Resistant Depression Healthcare Workers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.2025-02-03

Related papers

Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01 Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Return of the psychedelics: Psilocybin for treatment resistant depression.Asian journal of psychiatry · 2016-12-01 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10 Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-07-21